EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Calpeptin improves the cognitive function in Alzheimer's disease‐like complications of diabetes mellitus rats by regulating TXNIP / NLRP3 inflammasome

Luyao Qiao, Shouqin Yi, Tianpei Li, Xin Pan, Gege Wang, Xu Liu, Min Li, Jun Min, Huahui Le, Zhenyu Tang iD

Journal of Diabetes Investigation · 2024

DOI: 10.1111/jdi.14292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2024. Verfasst von Luyao Qiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Inflammasomes, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, The Applied Program of the Health Commission of Jiangxi Province, Natural Science Foundation of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Diabetes mellitus (DM) is closely associated with Alzheimer's disease (AD), and is considered an accelerator of AD. Our previous study has confirmed that the Calpain inhibitor Calpeptin may alleviate AD‐like complications of diabetes mellitus. This work further investigated its underlying mechanism. Materials and Methods Diabetes mellitus rat model was constructed by a high‐fat and high‐sugar diet combined with streptozotocin, followed by the administration of Calpeptin. Moreover, rats were micro‐injected with LV‐TXNIP‐OE/vector into the CA1 region of the hippocampus one day before streptozotocin injection. The Morris water maze test assessed the spatial learning and memory ability of rats. Immunohistochemistry and western blotting detected the expression of the pericyte marker PDGFRβ, tight junction proteins occludin and ZO‐1, calpain‐1, calpain‐2, APP, Aβ, Aβ‐related, and TXNIP/NLRP3 inflammasome‐related proteins. Immunofluorescence staining examined the blood vessel density and neurons in the hippocampus. Evans blue extravasation and fluorescence detected the permeability of the blood–brain barrier (BBB) in rats. Additionally, the oxidative stress markers and inflammatory‐related factors were assessed by enzyme‐linked immunosorbent assay.

Results

Calpeptin effectively reduced the expression of Calpain‐2 and TXNIP/NLRP3 inflammasome‐related proteins, improved the decreased pericyte marker (PDGFR‐β) and cognitive impairment in hippocampus of DM rats. The neuronal loss, microvessel density, permeability of BBB, Aβ accumulation, inflammation, and oxidative stress injury in the hippocampus of DM rats were also partly rescued by calpeptin treatment. The influence conferred by calpeptin treatment was reversed by TXNIP overexpression.

Conclusions

These data demonstrated that calpeptin treatment alleviated AD‐like symptoms in DM rats through regulating TXNIP/NLRP3 inflammasome. Thus, calpeptin may be a potential drug to treat AD‐like complications of diabetes mellitus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinAlzheimer DiseaseInflammasomesDiabetes Mellitus, ExperimentalRats, Sprague-DawleyAnimalsRatsMaleDipeptidesCarrier ProteinsCognitionBlood-Brain BarrierCell Cycle ProteinsOxidative StressHippocampusThioredoxins

Stichwörter der Autor:innen

Alzheimer's disease‐like complications of DMCalpain‐2TXNIP/NLRP3 inflammasome

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinTXNIP protein, ratInflammasomesNlrp3 protein, ratDipeptidesCarrier ProteinsCell Cycle ProteinsThioredoxins

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Department of Neurology, Institute of Neuroscience, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

ORCID-Profile: Zhenyu Tang

Förderung

  • National Natural Science Foundation of China
  • The Applied Program of the Health Commission of Jiangxi Province
  • Natural Science Foundation of Jiangxi Province

Zitieren

APA

Qiao, L., Yi, S., Li, T., Pan, X., Wang, G., Liu, X., Li, M., Min, J., Le, H., & Tang, Z. (2024). Calpeptin improves the cognitive function in Alzheimer's disease‐like complications of diabetes mellitus rats by regulating TXNIP / NLRP3 inflammasome. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14292

Vancouver

Qiao L, Yi S, Li T, Pan X, Wang G, Liu X, et al. Calpeptin improves the cognitive function in Alzheimer's disease‐like complications of diabetes mellitus rats by regulating TXNIP / NLRP3 inflammasome. Journal of Diabetes Investigation. 2024. doi:10.1111/jdi.14292

BibTeX
@article{Qiao2024,
  author = {Qiao, Luyao and Yi, Shouqin and Li, Tianpei and Pan, Xin and Wang, Gege and Liu, Xu and Li, Min and Min, Jun and Le, Huahui and Tang, Zhenyu},
  title = {Calpeptin improves the cognitive function in Alzheimer's disease‐like complications of diabetes mellitus rats by regulating TXNIP / NLRP3 inflammasome},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  doi = {10.1111/jdi.14292}
}
Kostenlos starten →